470 likes | 486 Views
Explore the use of neuromodulation techniques like HF-rTMS in alcohol addiction treatment and the predictive value of alcohol-related cues for relapse after therapy. Discover the effectiveness of non-invasive (tDCS, TMS) and invasive (DBS, VNS, ECT) techniques.
E N D
Addiction Therapy 2015Florida, USAAugust 03-08, 2015 Sarah Herremans
The predictive value of alcohol-related cues for relapse after accelerated HF-rTMS treatment in alcohol addiction Herremans Sarah
Overview • Neuromodulation techniques and addiction • HF-rTMS and alcohol addiction • Alcohol relapse and accelerated HF-rTMS titel
Neuromodulation techniques • Non-invasive techniques transcranial direct current stimulation (tDCS) transcranial magnetic stimulation (TMS) • Invasive techniques deep brain stimulation (DBS) vagal nerve stimulation (VNS) electroconvulsive therapy (ECT) titel
tDCS and substance dependence • Nicotine: Fregni et al., 2008: 24 subjects, stimulation of DLPFC (dorsolateral prefrontal cortex) Each subject: 1 placebo, 1 anodal left/cathodal right and 1anodal right/cathodal left stimulation => craving (cue-exposure) in bothactivestimulationconditions Boggio et al., 2009: 27 subjects, randomized, double blind, placebo-controlled Stimulation of the DLPFC, during 5 consecutivedays (anodalleft/cathodal right) => Increasingly craving (cue-exposure) over time
tDCS and substance dependence • Alcohol: Boggio et al., 2009: 13 subjects, stimulation of DLPFC, randomized placebo-controlled Each subject: 1 placebo, 1 anodal left/cathodal right & 1 anodal right/cathodal left stimulation craving (cue-exposure) in both ACTIVE stimulation conditions • Cannabis: Boggio et al., 2010: 25 cannabis users – 3 groups -randomized placebo - an anodal left/cathodal right - an anodal right/cathodal left => craving only for anodal right/cathodal left stimulation
Neuromodulation techniques • Non-invasive techniques transcranial direct current stimulation (tDCS) transcranial magnetic stimulation (TMS) • Invasive techniques deep brain stimulation (DBS) vagal nerve stimulation (VNS) electroconvulsive therapy (ECT) titel
DBS and substance dependence • DBS in substance dependence as a comorbid disorder => case reports (Kuhn, 2007, 2009; Mantione, 2010) • DBS in substance dependence as primary disorder Voges, 2013 : 5 treatment-resistant alcohol-dependent pts => decrease in relapse rate or abstinence Kuhn, 2011: 2 TR heroïne dependent patients => decrease in relapse rate Stimulation place: nucleus accumbens In animals: nucleus accumbens, insula, medial forebrain bundle, subthalamic nucleus, lateral habenula
Neuromodulation techniques • Non-invasive techniques transcranial direct current stimulation (tDCS) transcranial magnetic stimulation (TMS) • Invasive techniques deep brain stimulation (DBS) vagal nerve stimulation (VNS) electroconvulsive therapy (ECT) titel
VNS and substance dependence • No human case studies • Liu et al., 2011: study with heroine dependent rats: inhibition of heroine reinstatement after heroine priming and after exposure to heroin cues
Neuromodulation techniques • Non-invasive techniques transcranial direct current stimulation (tDCS) transcranial magnetic stimulation (TMS) • Invasive techniques deep brain stimulation (DBS) vagal nerve stimulation (VNS) electroconvulsive therapy (ECT) titel
ECT and substance dependence • Outdated!!! • 1966: Roper et al.: effective in 4 of 6 cases, most of them were morphine-dependent • After that nothing was published …Reason??? Possibly because APA did not specify addiction as an indication in ECT guidelines
Overview • Neuromodulation techniques and addiction • HF-rTMS and alcohol addiction • Alcohol relapse and accelerated HF-rTMS titel
Repetitive TMS (rTMS) High Frequency vs Low Frequency DLPFC Ridding & Rothwell, 2007 titel
Previous research (2012,2013) 1 HF-rTMSsession at Right DLPFC CravingCognition Response Inhibition Attentional Control Detoxified alcohol-dependent patients Randomized placebo controlled cross-over
Go-NoGotask(Zimmerman & Fimm, 1992) ATTENTIONAL CONTROL RESPONSE INHIBITION OCDS Go NoGo
Study Design 1 WEEK Active HF-rTMS Placebo HF-rTMS Go-NoGo task OCDS 50 pts 29 pts Placebo HF-rTMS Active HF-rTMS 1 WEEK OCDS until three days after the stimulation
Results • No effect on craving (until three days after the stimulation) • No effect on response inhition • Increase in attentional control => distractibility
Mutiple HF-rTMS sessions Mishra et al, 2015 Höppner et al, 2011 10 daily sessions left DLPFC alcohol craving No difference in anti-craving efficacy in both groups 20 detoxified alcohol-dependent patients 10 daily sessions right DLPFC Mishra et al, 2010: 14% relapsed in the active stimulation 33% in the placebo stimulation titel
Relapse • Often (80 -> 92% in one year ) • Definition: binary (yes or no drink) different outcomes • Pharmacological/psychotherapy not always beneficial • only 30% in actual treatment; reasons for this treatment gap: - problem is not acknowledged - the desire to not involve outside help/ that the treatment is not effective - the belief that the problem will pass by itself - stigma - financial problems,… titel
Predictors of relapse • Craving • Stress • Severity of alcohol dependence • Cognitive dysfunction, especially impaired response inhibition • Changes/Adaptations at the neurobiological level titel
Neurobiological predictors of relapse Nucleus accumbens precuneus A CC vmPFC De Raedt et al., 2010 Seo et al., 2013 titel
Overview • Neuromodulation techniques and addiction • HF-rTMS and alcohol addiction • Alcohol relapse and accelerated HF-rTMS titel
Goal 1 Can we predict alcohol relapse afteraccelerated HF-rTMS treatment based on baselinebrainactivationduring a cue-exposure? titel
Hypothesis 1 Hyperactivation during the alcohol-related stimuli => ABSTAINERS titel
Goal 2 How does 15ACCELERATED HF-rTMS sessionsinfluencethe relapse neurocircuitry in detoxified alcohol-dependentpatients? titel
Hypothesis 2 HF-rTMS only affects the relapse neurocircuit in ABSTAINERS titel
Study design Right DLPFC 20 Hz 1560p/session 15 accelerated sessions over 1 week Four weeks after the last fMRI: “have you already consumed an alcoholic beverage?” titel
29recently detoxified (benzodiazepines) alcohol-dependent patients were included over one year • 10 patients were lost to follow-up • 19 patients: 13 relapsers, 6 abstainers titel
Relapse rate • 68% High! • Compared to Mishra et al, 2010 much higher! • Not easy to compare since we used accelerated protocol • Accelerated protocol less efficient? • Mean duration of alcohol addiction of our patients +/- 5 years longer • Comparable to studies assessing naltrexone, acamprosate (Laaksonen et al., 2008) titel
Neurobiological level titel
ANOVA – ROI analysis: Interaction cluster P<0.001 AlphaSim corrected titel
Baseline – Before accelerated HF-rTMS dACC Abstainers > Relapsers => cognitive control Hypothesis 1 ! titel
Effect of HF-rTMS • Abstainers: dACC activation • Relapsers: dACC activation ! After HF-rTMS = Hypothesis 2 titel
Rate-dependent effect Contrast: alcohol > neutral Rate-dependent effect titel
How can we interpret? • In detoxified hospitalized patients • During exposure to alcoholstimuli • Is HF-rTMS relevant in patients with high baseline dACC activation (abstainers)? • Patients with a low baseline dACC activation (relapsers) have a larger proportional increase of dACC activation, but withouta clinical effect? short duration of action? dosage? titel
Limitations • No placebo stimulation • No control group that received treatment as usual was assessed 4 weeks after discharge • Only info about alcohol lapses titel
Future research • Patients with lowdACC activity larger number of placebo-controlled HF-rTMS interventions • Optimize HF-rTMS parameters titel
Take away message • 15 accelerated HF-rTMS sessions in detoxified alcohol-dependent patients: • High relapse rate (68%) • Abstaining patients: more cognitive control (dACC) • Accelerated HF-rTMS has a rate-dependent effect on dACC activation • Only a limited effect at the clinical level (HF-rTMS effect probably short-lived) titel
Thank you for your attention! Collaborators: Chris Baeken, MD, PHD Frieda Matthys, MD, PHD Peter Van Schuerbeek, MSc Rudi De Raedt, PhD, Johan De Mey, MD, PhD Daniele Marinazzo, PhD titel
Meet the eminent gathering once again atAddiction Therapy 2016Miami, USAOctober 06-08, 2016 Addiction Therapy 2016 Website: addictiontherapy.conferenceseries.com